Cefuroxime Axetil USP 125 mg/5 ml

Business Unit: Human

Medicine Type: Dry Syrup

Generic Name: Cefuroxime Axetil USP 125 mg/5 ml

Therapeutic Class: Second generation Cephalosporins

Indication: Cefuxet (Cefuroxime axetil) is indicated for the treatment of infections caused by sensitive bacteria like Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, Acute bacterial maxillary sinusitis, Lower respiratory tract infections including pneumonia, Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis, Skin and skin-structure infections, Urinary tract infections, Bone and Joint Infections, Gonorrhea, Early Lyme Disease.

Dosage & Administration: Tablet or Suspension- Adolescents and adults (13 years and older)- • Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days • Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days • Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days • Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days • Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days • Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days • Uncomplicated Gonorrhea: 1000 mg Single dose • Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days • MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days • Early Lyme disease: 500 mg b.i.d. for 20 days Pediatric Patients (3 months to 12 years)- • Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days • Acute otitis media: 30 mg/kg/day b.i.d for 10 days • Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days • Impetigo: 30 mg/kg/day b.i.d for 10 days

Preparation: 70 ml Dry Syrup